benidipine has been researched along with Disease Exacerbation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kazama, I | 1 |
| Baba, A; Ejima, Y; Endo, Y; Kazama, I; Matsubara, M; Toyama, H | 1 |
| Abe, M; Maruyama, N; Maruyama, T; Matsumoto, K; Okada, K | 1 |
| Inoue, S; Tomino, Y | 1 |
| Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kitakaze, M; Liao, Y; Minamino, T; Ogai, A; Takashima, S; Tomoike, H | 1 |
| Kawachi, H; Nakamura, T; Obata, JE; Onitsuka, M; Shimada, Y; Shimizu, F; Yoshida, Y | 1 |
| Saruta, T; Suzuki, H | 1 |
1 review(s) available for benidipine and Disease Exacerbation
| Article | Year |
|---|---|
Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Electrophysiological Phenomena; Humans; Immunologic Factors; Kidney; Kv1.3 Potassium Channel; Leukocytes; Macrolides; Membrane Potentials; Renal Insufficiency, Chronic; T-Lymphocytes | 2015 |
2 trial(s) available for benidipine and Disease Exacerbation
| Article | Year |
|---|---|
Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
Topics: Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Protective Agents; Proteinuria | 2009 |
Effects of calcium antagonists in hypertensive patients with renal dysfunction: a prospective, randomized, parallel trial comparing benidipine and nifedipine.
Topics: Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Humans; Hypertension; Hypertension, Renovascular; Male; Middle Aged; Nifedipine; Prospective Studies | 2004 |
4 other study(ies) available for benidipine and Disease Exacerbation
| Article | Year |
|---|---|
Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
Topics: Animals; Blood Urea Nitrogen; Calcium Channel Blockers; Cell Proliferation; Creatinine; Cytokines; Dihydropyridines; Disease Models, Animal; Disease Progression; Fibrosis; Kidney; Kidney Failure, Chronic; Kv1.3 Potassium Channel; Leukocytes; Male; Nephrectomy; Rats; Rats, Sprague-Dawley | 2014 |
Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Topics: Animals; Biomarkers; Calcium Channel Blockers; Cardiomegaly; Cells, Cultured; Collagen Type IV; Dihydropyridines; Disease Progression; Gene Expression Regulation; Heart Failure; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide; Signal Transduction; Ventricular Remodeling | 2005 |
Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Topics: Actins; Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Creatinine; Dihydropyridines; Disease Models, Animal; Disease Progression; Fluorescent Antibody Technique; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Kidney Glomerulus; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Transforming Growth Factor beta; Vasodilator Agents | 2000 |
Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Creatine; Dihydropyridines; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome | 2001 |